Regeneron Pharmaceuticals is one of the most successful companies in the Health Care sector. As of the year 2018, it generated revenues of $5,872 million (20.80% year-over-year change). Reported profit was of $1,198.50 million. The current CEO Leonard S. Schleifer (President, Chief Executive Officer & Director) currently manages more than 6,200 employees. The company's headquarters is located in Tarrytown, NY. Yes, Regeneron Pharmaceuticals is a Fortune 1000 company. Its current rank is top 473 US company. It has been on the list for 1 years.
- Berkshire Hathaway
- AGL Energy Limited